MADISON, Wis.--(BUSINESS WIRE)--EraGen Biosciences Inc. today announced that it has applied the $244,500 grant it was awarded recently through the Qualifying Therapeutic Discovery Project Program to support the expansion of the company’s manufacturing operations.
